FGD1靶向药基因

基因名称:FGD1  (FYVE, RhoGEF and PH domain containing 1)

别名: AAS,FGDY,MRXS16,ZFYVE3
基因ID:2245
Chromosome(GRCh37) :X Start: 54471887 End: 54522599 Strand:
信号通路:
靶向药:
化疗药:

简介:该基因编码一种含有dbl(dh)和pleckstrin(ph)同源结构域的蛋白质,与小gtp结合蛋白rho家族相似。编码蛋白与Rho家族GTPase-Cdc42Hs特异性结合,能刺激Cdc42Hs等肾素化形式的GDP-GTP交换它还刺激丝裂原活化蛋白激酶级联反应,导致c-Jun激酶SAPK/JNK1活化该基因缺陷是导致Aarskog-Scott综合征面部发育不良和X连锁认知功能障碍的一种综合征形式的原因。[由RefSeq提供,2017年7月]This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]
FGD1突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务